naringenin has been researched along with Adrenocortical Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denison, MS; Hordijk, J; Nantz, MH; Sanderson, JT; Springsteel, MF; van den Berg, M | 1 |
1 other study(ies) available for naringenin and Adrenocortical Carcinoma
Article | Year |
---|---|
Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells.
Topics: Adrenal Gland Neoplasms; Adrenocortical Carcinoma; Apigenin; Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Induction; Flavanones; Flavonoids; Humans; Rotenone; Structure-Activity Relationship | 2004 |